BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6804217)

  • 1. Alterations in the responsiveness of median eminence luteinizing hormone-releasing hormone nerve terminals to norepinephrine and prostaglandin E2 in vitro during the rat estrous cycle.
    DePaolo LV; Ojeda SR; Negro-Vilar A; McCann SM
    Endocrinology; 1982 Jun; 110(6):1999-2005. PubMed ID: 6804217
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative feedback effects of progesterone correlated with changes in hypothalamic norepinephrine and dopamine turnover rates, median eminence luteinizing hormone-releasing hormone, and peripheral plasma gonadotropins.
    Rance N; Wise PM; Barraclough CA
    Endocrinology; 1981 Jun; 108(6):2194-9. PubMed ID: 6785075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine turnover rates in discrete hypothalamic areas and associated changes in median eminence luteinizing hormone-releasing hormone and serum gonadotropins on proestrus and diestrous day 1.
    Rance N; Wise PM; Selmanoff MK; Barraclough CA
    Endocrinology; 1981 May; 108(5):1795-802. PubMed ID: 6783392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of central catecholamines in the feedback actions of 17beta-estradiolbenzoate on luteinizing hormone secretion in the ovariectomized female rat.
    Fuxe K; Löfström A; Eneroth P; Gustafsson JA; Skett P; Hökfelt T; Wiesel FA; Agnati L
    Psychoneuroendocrinology; 1977; 2(3):203-25. PubMed ID: 333495
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal monosodium glutamate treatment alters the response of median eminence luteinizing hormone-releasing hormone nerve terminals to potassium and prostaglandin E2.
    DePaolo LV; Negro-Vilar A
    Endocrinology; 1982 Mar; 110(3):835-41. PubMed ID: 7035149
    [No Abstract]   [Full Text] [Related]  

  • 6. Attenuation during aging of the postovariectomy rise in median eminence catecholamines.
    Wilkes MM; Yen SS
    Neuroendocrinology; 1981 Sep; 33(3):144-7. PubMed ID: 6793883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of alpha-adrenergic receptors in norepinephrine-induced prostaglandin E2 and luteinizing hormone-releasing hormone release from the median eminence.
    Ojeda SR; Negro-Vilar A; McCann SM
    Endocrinology; 1982 Feb; 110(2):409-12. PubMed ID: 6276133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The innervation of the hypothalamic median eminence.
    Cuello AC; Iversen LL
    Res Reprod; 1974 Jan; 6(1):3-4. PubMed ID: 4619841
    [No Abstract]   [Full Text] [Related]  

  • 9. Semi-quantitative ultrastructural analysis of the localization and neuropeptide content of gonadotropin releasing hormone nerve terminals in the median eminence throughout the estrous cycle of the rat.
    Prevot V; Dutoit S; Croix D; Tramu G; Beauvillain JC
    Neuroscience; 1998 May; 84(1):177-91. PubMed ID: 9522372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline and prostaglandin E2 stimulate LH-RH release from rat median eminence through distinct 1-alpha-adrenergic and PGE2 receptors.
    Heaulme M; Dray F
    Neuroendocrinology; 1984 Nov; 39(5):403-7. PubMed ID: 6096749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholaminergic modulation of luteinizing hormone-releasing hormone release by median eminence terminals in vitro.
    Negro-Vilar A; Ojeda SR; McCann SM
    Endocrinology; 1979 Jun; 104(6):1749-57. PubMed ID: 221191
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of indomethacin, an inhibitor of prostaglandin synthesis, on the hypothalamic-pituitary system in rats.
    Sato T; Jyujo T; Hirono M; Iesaka T
    J Endocrinol; 1975 Feb; 64(2):395-6. PubMed ID: 1090695
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effects of RU 16117, a potent estrogen antagonist, on the estrous cycle in the rat.
    Ferland L; Labrie F; Kelly PA; Raynaud JP
    Biol Reprod; 1978 Feb; 18(1):99-104. PubMed ID: 342001
    [No Abstract]   [Full Text] [Related]  

  • 14. Definitive evidence for the existence of morphological plasticity in the external zone of the median eminence during the rat estrous cycle: implication of neuro-glio-endothelial interactions in gonadotropin-releasing hormone release.
    Prevot V; Croix D; Bouret S; Dutoit S; Tramu G; Stefano GB; Beauvillain JC
    Neuroscience; 1999; 94(3):809-19. PubMed ID: 10579572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of norepinephrine and dibenamine implanted in the median eminence on the estrous cycle of the rat.
    Uemura H; Kobayashi H
    Horm Res; 1974; 5(2):89-111. PubMed ID: 4855786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of preovulatory gonadotropin secretion and stimulation of prolactin secretion by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats.
    Kerdelhue B; El Abed A
    Cancer Res; 1979 Nov; 39(11):4700-5. PubMed ID: 115578
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that a short-lived effect of copper leads to amplification of prostaglandin E2 stimulation of the release of gonadotropin-releasing hormone from median eminence explants.
    Barnea A; Cho G; Colombani-Vidal M
    Endocrinology; 1986 Sep; 119(3):1254-61. PubMed ID: 3525128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of cyclic adenosine 3',5'-monophosphate production enhances hypothalamic luteinizing hormone-releasing hormone release without increasing prostaglandin E2 synthesis: studies in prepubertal female rats.
    Ojeda SR; Urbanski HF; Katz KH; Costa ME
    Endocrinology; 1985 Sep; 117(3):1175-8. PubMed ID: 2410236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal alterations in luteinizing hormone-releasing hormone concentrations in several discrete brain regions: effects of estrogen-progesterone and norepinephrine synthesis inhibition.
    Simpkins JW; Kalra PS; Kalra SP
    Endocrinology; 1980 Aug; 107(2):573-7. PubMed ID: 6248329
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of estradiol-positive feedback at puberty: estradiol sensitizes the LHRH-releasing system at two different biochemical steps.
    Ojeda SR; Urbanski HF; Katz KH; Costa ME
    Neuroendocrinology; 1986; 43(2):259-65. PubMed ID: 3523279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.